comparemela.com

Latest Breaking News On - American society of clinical oncology annual meeting - Page 3 : comparemela.com

Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib

CAMBRIDGE, Mass., June 01, 2024 Cullinan Therapeutics, Inc. , a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced positive initial data in.

Virginia
United-states
Cambridge
Cambridgeshire
United-kingdom
Chad
American
Rose-weldon
Jeffrey-jones
Jeff-jones
Alexander-spira
Globenewswire-inc

Adcetris Regimen Outperforms Intense Chemo in Classical Hodgkin Lymphoma

An Adcetris-based treatment regimen improved progression-free survival and was more tolerable for patients with classical Hodgkin lymphoma.

United-states
American
Peter-borchmann
University-hospital-cologne
American-society-of-clinical-oncology-annual-meeting
Clinical-oncology-annual
Integrated-oncology

Rybrevant Plus Leclaza May Be New Standard for EGFR-Mutant Lung Cancer

Rybrevant plus Leclaza outperformed Tagrisso regarding progression-free survival in patients with EGFR-mutant non-small cell lung cancer.

Spain
Barcelona
Comunidad-autonoma-de-cataluna
United-states
American
Rybrevant-leclaza
Enriqueta-felip
American-society-of-clinical-oncology-annual-meeting
Clinical-oncology-annual-meeting
Neck-cancer-unit
Hebron-hospital

Rybrevant Plus Leclaza Has 'Very Potent Activity' in Lung Cancer Subset

Rybrevant plus Leclaza had promising response and progression-free survival rates in patients with EGFR-mutant non-small cell lung cancer.

South-korea
United-states
American
Byoung-chul-cho
Yonsei-cancer-center
American-society-of-clinical-oncology-annual-meeting
Clinical-oncology-annual

FutureBridge set to engage with industry leaders at 2024 ASCO® Annual Meeting and BIO 2024 International Conference

UTRECHT, Netherlands, May 30, 2024 /PRNewswire/ FutureBridge, a leading techno-commercial consulting and advisory company focussing on R&D, innovation, strategy, scientific evidence, markets

United-states
Netherlands
San-diego
California
Chicago
Illinois
American
Prnewswire-futurebridge
Manoj-jiandani
Shivali-jasrotia
Amgen
Astrazeneca

vimarsana © 2020. All Rights Reserved.